Paper3977705
Botulinum A toxin injection as a treatment for blepharospasm.
Scott AB and 2 others. Arch Ophthalmol, 1985. Cited by 358 papers, by iCite.
Cite this record
ConductScience Library. Botulinum A toxin injection as a treatment for blepharospasm. Papers, record 3977705. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3977705
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blepharospasm | Major topic |
| Botulinum Toxins | Major topic |
| Eyelid Diseases | Major topic |
| Eyelids | |
| Humans | |
| Muscles |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P-30-EY-01186 | NEI NIH HHS | United States | P30EY001186 | PubMed and NIH | NIH RePORTER |
| R0-1-EY-02106 | NEI NIH HHS | United States | R01EY002106 | PubMed and NIH | NIH RePORTER |
| R0-1-EY-03153 | NEI NIH HHS | United States | R01EY003153 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01691651 | Botulinum Toxin A for the Treatment of Keratoconus | Background |
Source ClinicalTrials.gov
Cited by79
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 358 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42291160 | Retrograde cricopharyngeus dysfunction (R-CPD), also known as inability to belch syndrome-a narrative review. | Transl Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42291160 | PubMed |
| 41180523 | Comparative analysis of onabotulinum toxin type-A injection techniques in older adults with blepharospasm: a retrospective cohort study. | Front Neurol | 2025 | https://conductscience.org/library/papers/41180523 | PubMed |
| 40864059 | Botulinum Neurotoxin A Injections in Spasmodic Entropion: A Clinical Retrospective Cohort Study. | Toxins (Basel) | 2025 | https://conductscience.org/library/papers/40864059 | PubMed |
| 39974230 | Short-Term Effects on Tear Film Following Cosmetic Botulinum Toxin Injections in Healthy Individuals. | Cureus | 2025 | https://conductscience.org/library/papers/39974230 | PubMed |
| 39139840 | Effectiveness of 0.3% Hyaluronic Acid Eye Drops for Benign Essential Blepharospasm and Hemifacial Spasm with Botulinum Toxin-induced Dry Eye. | Plast Reconstr Surg Glob Open | 2024 | https://conductscience.org/library/papers/39139840 | PubMed |
| 38922160 | Update on Non-Interchangeability of Botulinum Neurotoxin Products. | Toxins (Basel) | 2024 | https://conductscience.org/library/papers/38922160 | PubMed |
| 38898766 | Investigating the impact of botulinum toxin type a on the migration of normal human dermal fibroblasts: An in vitro wound healing assay. | J Cosmet Dermatol | 2024 | https://conductscience.org/library/papers/38898766 | PubMed |
| 37499081 | Treatment of cervical dystonia with Botox (onabotulinumtoxinA): Development, insights, and impact. | Medicine (Baltimore) | 2023 | https://conductscience.org/library/papers/37499081 | PubMed |
| 37499080 | Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): Development, insights, and impact. | Medicine (Baltimore) | 2023 | https://conductscience.org/library/papers/37499080 | PubMed |
| 37061220 | TFOS Lifestyle: Impact of cosmetics on the ocular surface. | Ocul Surf | 2023 | https://conductscience.org/library/papers/37061220 | PubMed |
| 36769526 | Botulinum Neurotoxin Type a Injection Combined with Absorbable Punctal Plug Insertion: An Effective Therapy for Blepharospasm Patients with Dry Eye. | J Clin Med | 2023 | https://conductscience.org/library/papers/36769526 | PubMed |
| 35202148 | Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A-30 Years of Experience in a Tertiary Care Center. | Toxins (Basel) | 2022 | https://conductscience.org/library/papers/35202148 | PubMed |
| 35086302 | Immunogenicity of botulinum toxin. | Arch Plast Surg | 2022 | https://conductscience.org/library/papers/35086302 | PubMed |
| 35067772 | Medical cannabis oil for benign essential blepharospasm: a prospective, randomized controlled pilot study. | Graefes Arch Clin Exp Ophthalmol | 2022 | https://conductscience.org/library/papers/35067772 | PubMed |
| 34571634 | Outcomes of a regional variant of botulinum toxin type A in the treatment of essential blepharospasm and hemifacial spasms: A retrospective study. | Indian J Ophthalmol | 2021 | https://conductscience.org/library/papers/34571634 | PubMed |
| 32602955 | Mechanism of Action of OnabotulinumtoxinA in Chronic Migraine: A Narrative Review. | Headache | 2020 | https://conductscience.org/library/papers/32602955 | PubMed |
| 31747112 | Association between cannabis and the eyelids: A comprehensive review. | Clin Exp Ophthalmol | 2020 | https://conductscience.org/library/papers/31747112 | PubMed |
| 31658795 | Treatment of post-traumatic chin deformities using bilateral botulinum toxin injections. | Arch Craniofac Surg | 2019 | https://conductscience.org/library/papers/31658795 | PubMed |
| 31258617 | Use of botulinum toxin for movement disorders. | Drugs Context | 2019 | https://conductscience.org/library/papers/31258617 | PubMed |
| 30678375 | A Review of Periocular Botulinum Neurotoxin on the Tear Film Homeostasis and the Ocular Surface Change. | Toxins (Basel) | 2019 | https://conductscience.org/library/papers/30678375 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3977705
GET https://conductscience.org/api/papers/v1/3977705/cited_by?page=2